| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GSE190803
|
||||||||
| GSM5732258 |
N2 strain; CTR treatment; rep 1
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732259 |
N2 strain; PAR1 treatment; rep 1
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732260 |
N2 strain; POS1 treatment; rep 1
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732261 |
N2 strain; CTR treatment; rep 2
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732262 |
N2 strain; PAR1 treatment; rep 2
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732263 |
N2 strain; POS1 treatment; rep 2
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732264 |
N2 strain; CTR treatment; rep 3
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732265 |
N2 strain; PAR1 treatment; rep 3
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732266 |
N2 strain; POS1 treatment; rep 3
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732267 |
QX1211 strain; CTR treatment; rep 1
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732268 |
QX1211 strain; PAR1 treatment; rep 1
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732269 |
QX1211 strain; POS1 treatment; rep 1
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732270 |
QX1211 strain; CTR treatment; rep 2
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732271 |
QX1211 strain; PAR1 treatment; rep 2
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732272 |
QX1211 strain; POS1 treatment; rep 2
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732273 |
QX1211 strain; CTR treatment; rep 3
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732274 |
QX1211 strain; PAR1 treatment; rep 3
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732275 |
QX1211 strain; POS1 treatment; rep 3
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732276 |
CB4856 strain; CTR treatment; rep 1
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 | |||
| GSM5732277 |
CB4856 strain; PAR1 treatment; rep 1
|
SRA | 1 |
|
Avery Davis Bell | Mar 23, 2023 |
